In the title homotripeptide {Boc-[Asp(OMe)] 3 -OPac}, C 28 H 37 N 3 O 13 , all peptide bonds adopt an s-trans conformation with respect to the N-H and C O groups. In the crystal, N-HÁ Á ÁO hydrogen bonds result in an infinite parallelsheet structure running along the b-axis direction. The Boc protecting group at the N-terminus of the peptide is disordered over two sites with occupancy factors of 0.504 (5) and 0.496 (5).
Chemical context
In peptide stereochemistry, many studies have been performed in order to control the peptide's secondary structure. Among them, controlling helix handedness can greatly impact the design of some biological molecules such as molecular switches and the pharmaceutical lead like proteinprotein interaction inhibitors (de Zotti et al., 2014) . Blout & Karlson (1958) reported that the homopolymer of aspartic acid -benzyl ester existed as a left-handed helix in solutions of halogenated hydrocarbones (CHCl 3 and CCl 2 COOH), although early studies have clearly shown that a classical ordered -helix structure in all-L peptides is right handed because of the absolute configuration of their -amino acid building blocks. Subsequently, this research topic was expanded by many other groups, and numerous -esters have been investigated (Toniolo et al., 1968) . In this work, we focus on the homo-tripeptide of Asp(OMe) as a simple model of the homo-polypeptide because of the difficulties in collecting X-ray diffraction data for polypeptides. Table 1 shows selected torsion angles for the title tripeptide. The molecular structure of the tripeptide adopts an extended conformation of the backbone chain ( Fig. 1) with the '-and -In the crystal, all of the N atoms in the tripeptide are engaged in intermolecular N-HÁ Á ÁO hydrogen bonds [N1-H1Á Á ÁO5A
Structural commentary
i , N1-H1Á Á ÁO5B i , N2-H2Á Á ÁO12 ii and N3-H3Á Á ÁO22 i ; Table 2 ]. These hydrogen bonds and some C-HÁ Á ÁO hydrogen bonds (C2A-H2A1Á Á ÁO4A
ii , C13-H13Á Á ÁO5A
i , C13-H13Á Á ÁO5B i , C31-H31Á Á ÁO35 ii , C33-H33AÁ Á ÁO41 i and C41-H41AÁ Á ÁO42 ii ; Table 2 ) link the molecules, forming an infinite parallel -sheet structure along the b-axis direction (Fig. 2 ). Other C-HÁ Á ÁO hydrogen bonds [C15-H15BÁ Á ÁO34
iii , C25-H25BÁ Á ÁO32 iv and C46- Table 2 Hydrogen-bond geometry (Å , ). 
Figure 1
The molecular structure of the title compound with displacement ellipsoids drawn at the 50% probability level. The minor component of the disordered group is drawn with dashed lines. 
Database survey
A search of the Cambridge Structural Database (Version 5.39, updated November 2017; Groom et al., 2016) for homodipeptides and tripeptides of Asp and Asp -esters yielded zero hits. A search for dipeptides having an Asp(OMe) residue yielded two hits [DOBWIA (Fuganti et al., 1986) and GABVEK (Mcharfi et al., 1986) ]. DOBWIA, an -l-aspartyll-phenylalanine derivative, has an extended intra-and intermolecular hydrogen-bonding network. GABVEK, an -lprolyl-l-aspartic acid derivative, shows a I-turn conformation.
Synthesis and crystallization
The synthesis of the title homotripeptide, 6, was performed according to the scheme in Fig. 4 . Compound 1 was synthesized from l-aspartic acid according to a previously described method (Reddy et al., 2011; Ollivier et al., 2010 Compound 2 was synthesized according to a slightly modified literature procedure (Wang et al., 1977) . Compound 1 (7.05 g, 28.5 mmol) was dissolved in MeOH (20 mL) and 0.7 M aqueous Cs 2 CO 3 solution (20 ml) was added. The mixture was evaporated to dryness and the residue was reevaporated three times with EtOH. A mixture of the white solid cesium salt and phenacyl bromide (5.68 g, 28.5 mmol) in DMF (30 mL) was stirred for 15min, and the precipitated cesium bromide removed. Compound 3: Compound 2 (0.67 g, 2.72 mmol) was treated with 4.0 M HCl in dioxane for 60 min. The excess of HCl and solvent were evaporated and the residue was re-evaporated three times with MeOH, which was used for the next reaction without purification.
Compound 4: A solution of compound 1 (1.01 g, 2.72 mmol), compound 3 (2.72 mmol), 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluoridophosphate (HBTU; 1.24 g, 3.26 mmol), 1,2,3-benzotriazol-1-ol monohydrate (HOBt; 0.44 g, 3.26 mmol) and i Pr 2 NEt (1.11 ml, 6.52 mmol) in DMF was stirred at room temperature for 20 h. The solution was then evaporated, diluted with ethyl acetate, washed with sat. aqueous KHSO 4 and sat. aqueous NaHCO 3 , and dried over Na 2 SO 4 . After evaporation of the solvent, the residue was purified by column chromatography on silica gel (50% EtOAc in n-hexane). Crystallization of the product from a mixture of ethyl acetate and hexane (v:v = 1:1) afforded colourless crystals. Yield 0.70 g (1.42 mmol, 52.4%). evaporated three times with MeOH, which was used for the next reaction without purification.
Compound 6: A solution of compound 1 (57.7 mg, 0.233 mmol), compound 5 (0.212 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (WSCHCl; 55.2 mg, 0.288 mmol), HOBt (37.1 mg, 0.275 mmol) and Et 3 N (71 ml, 0.509 mmol) in DMF was stirred at room temperature for 20 h. The solution was then evaporated, diluted with ethyl acetate, washed with sat. aqueous KHSO 4 and sat. aqueous NaHCO 3 , and dried over Na 2 SO 4 . After evaporation of the solvent, the residue was purified by column chromatography on silica gel (66% EtOAc in n-hexane). Crystallization of the product from a mixture of ethyl acetate and hexane (v:v = 1:1) afforded colourless crystals. Yield 77 mg (0.127 mmol, 59.9%). 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 . The Boc protecting group at the Nterminus of the peptide is disordered. The final occupancy ratio is 0.504 (5):0.496 (5). The C atoms of the disordered tertbutyl groups were refined with SIMU restraints and the C5-O5A and C5-O5B bonds were treated with DFIX restraints of 1.21 (1) Å . The N-bound H atoms were refined freely, while the other H atoms were placed in geometrically idealized positions (C-H = 0.95-1.00 Å ) and refined as riding on their parent atoms, with U iso (H) = 1.2U eq (C) (or 1.5U eq (C) for the methyl groups). The absolute configuration was known for the synthesized material.
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Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (
